Z

Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332

Watchlist Manager
Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
Watchlist
Price: 10.28 CNY -0.87%
Market Cap: 10.2B CNY
Have any thoughts about
Zhejiang Xianju Pharmaceutical Co Ltd?
Write Note
Zhejiang Xianju Pharmaceutical Co Ltd
/
Income Statement
/
Net Income (Common)

Zhejiang Xianju Pharmaceutical Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zhejiang Xianju Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zhejiang Xianju Pharmaceutical Co Ltd
SZSE:002332
Net Income (Common)
¥621.7m
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
30%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Net Income (Common)
¥3.3B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Net Income (Common)
¥3.1B
CAGR 3-Years
9%
CAGR 5-Years
18%
CAGR 10-Years
23%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Net Income (Common)
¥5.4B
CAGR 3-Years
-5%
CAGR 5-Years
2%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Net Income (Common)
¥4.3B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
6%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Net Income (Common)
-¥780.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zhejiang Xianju Pharmaceutical Co Ltd
Glance View

Market Cap
10.2B CNY
Industry
Pharmaceuticals

In the heart of eastern China, Zhejiang Xianju Pharmaceutical Co., Ltd. stands as a testament to China's evolving pharmaceutical prowess. Founded in 1972, Xianju Pharmaceutical has carved out a niche in the global healthcare market by specializing in the production of corticosteroids and hormone APIs (Active Pharmaceutical Ingredients). What sets Xianju apart is its relentless focus on research and development, enabling the company to produce a wide array of steroid and hormone products that cater to both domestic and international markets. The innovation pipeline is fueled by a robust R&D team that ensures the company remains at the forefront of pharmaceutical advancements, allowing it to consistently meet the stringent quality standards expected in this highly regulated industry. The company's financial engine runs on its ability to manufacture these high-demand products efficiently and at scale, leveraging advanced technologies and integrated production processes. This operational efficiency provides Xianju a competitive edge in price stability and market reach. The revenue stream is diversified yet strategically concentrated on its core competencies, allowing Xianju to capitalize on rising global demands for hormone therapies and steroid-related medical treatments. By maintaining strong relationships with global partners and continuously expanding its distribution networks, Zhejiang Xianju Pharmaceutical not only sustains its profitability but also plays a critical role in shaping healthcare outcomes around the world. The company's growth trajectory suggests a finely balanced strategy that combines innovation, production excellence, and market expansion.

Intrinsic Value
17.51 CNY
Undervaluation 41%
Intrinsic Value
Price
Z
What is Intrinsic Value?

See Also

What is Zhejiang Xianju Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
621.7m CNY

Based on the financial report for Sep 30, 2024, Zhejiang Xianju Pharmaceutical Co Ltd's Net Income (Common) amounts to 621.7m CNY.

What is Zhejiang Xianju Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
30%

Over the last year, the Net Income (Common) growth was -10%. The average annual Net Income (Common) growth rates for Zhejiang Xianju Pharmaceutical Co Ltd have been 1% over the past three years , 10% over the past five years , and 30% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.